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Abstract
Background: The purpose of this study was to describe the sleep structure (especially slow wave sleep) in adults with
congenital central hypoventilation syndrome (CCHS), a rare genetic disease due to mutations in the PHOX2B gene.
Fourteen patients aged 23 (19.0; 24.8) years old (median [1rst-3rd quartiles]) with CCHS underwent a sleep interview and
night-time attended polysomnography with their ventilatory support. Their sleep variables were compared to those
collected in 15 healthy control subjects matched for age, sex and body mass index.
Results: The latency to N3 sleep was shorter in patients (26.3 min [24.0; 30.1]) than in controls (49.5 min [34.3; 66.9];
P = 0.005), and sleep onset latency tended to be shorter in patients (14.0 min [7.0; 20.5]) than in controls (33.0 min
[18.0; 49.0]; P = 0.052). Total sleep time, sleep stage percentages, sleep fragmentation as well as respiratory and
movement index were within normal ranges and not different between groups.
Conclusions: Normal sleep in adult patients with CCHS and adequate ventilator support indicates that the PHOX2
gene mutations do not affect brain sleep networks. Consequently, any complaint of disrupted sleep should prompt
clinicians to look for the usual causes of sleep disorders, primarily inadequate mechanical ventilation. Shorter N3
latency may indicate a higher need for slow wave sleep, to compensate for the abnormal respiratory-related cortical
activity during awake quiet breathing observed in patients with CCH.
Keywords: Congenital central hypoventilation syndrome, Ondine’s curse syndrome, Sleep structure, Polysomnography,
Slow wave sleep, Local sleep, Mechanical ventilation
Background
Congenital central hypoventilation syndrome (CCHS) is
a rare genetic disease caused by mutations of the
PHOX2B gene [1]. The syndrome is associated with
multiple autonomic nervous system disorders. Patients
with CCHS have profoundly impaired sensitivity to car-
bon dioxide and suffer from profound sleep-related
hypoventilation. Consequently, right from birth, their
survival depends on mandatory ventilatory assistance
during sleep. Clinical practice guidelines stipulate that
polysomnography should be performed in patients with
CCHS on a regular basis, twice-yearly then yearly, to as-
sess ventilatory needs in all sleep stages [2]. However, no
published data are available concerning sleep structure
and sleep quality in patients with CCHS, although sev-
eral factors could impact sleep architecture, including
mechanical ventilation-related sleep alterations (e.g., giv-
ing rise to frequent alarms), as well as putative neurode-
velopmental abnormalities due to the genetic defect, as
observed in other genetic disorders, [3] changes in circa-
dian rhythms (as already documented in children with
CCHS [4]), or chronic anxiety (frequent in adult patients
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with CCHS [5]). In addition, adult patients with CCHS
exhibit respiratory-related motor cortical activity during
awake resting breathing, which is absent in normal indi-
viduals [6]. This activity is interpreted as a cooperative
wake-related cortical mechanism supplementing the de-
ficient medullary ventilatory drive [6]. This hypothesis
has recently been supported by the observation of simi-
lar cortical activity in normal subjects continuing to
breathe despite experimental hypocapnia, namely in a
situation in which medullary ventilatory drive is reduced
[7]. Because activation of neuronal populations during
wakefulness may be followed by higher local sleep in the
corresponding cortical areas (as shown by increased
local slow wave sleep activity after a localized learning
task [8] or after excitatory repetitive transcranial mag-
netic stimulation [9]), the respiratory-related cortical ac-
tivity observed in CCHS could increase slow wave sleep.
Consequently, this study was designed to compare sleep
structure (especially slow wave sleep) in adult patients
with CCHS vs. healthy controls.
Methods
Participants
Fourteen of the 17 adult patients with CCHS followed at
the adult branch of the French national reference center
for this disease at the time of the study were included
(age: 23 [22; 26] years old, median [1rst-3rd quartile]).
To ensure a homogeneous study population comparable
to the control population, three patients from the adult
CCHS cohort were not included (two patients with late
onset CCHS -one woman aged 49 and one man aged 37
at the time of the diagnosis-, and one 27-year-old patient
with a neonatal diagnosis of CCHS -frameshift muta-
tion- but documented anoxic brain lesions and severe
psychiatric disorders requiring psychotropic treatment
most likely to affect sleep). All included patients had
been diagnosed with CCHS soon after birth and, for the
first 18 years of life, had been followed-up at least annu-
ally by the French reference center for CCHS, in
addition to their usual care and home mechanical venti-
lation management. PHOX2B abnormalities consisted of
alanine expansion in 13 cases (25 alanine, n = 5; 26, n =
3; 27, n = 2; 29, n = 1; 30, n = 1 and 31, n = 1) and frame-
shift mutation in 1 case. None of the patients had a his-
tory of cor pulmonale or polycythemia or any other
evidence suggesting insufficient ventilatory support.
Serum hemoglobin was 13.1 [12.6–13.6] g/100 ml at the
time of polysomnography. None of the patients included
in the study had gross evidence of neurocognitive delay.
All patients had completed a normal schooling program
in the French system since early childhood. At the time
of the study, six were still attending secondary school,
five had graduated at the end of high school, and 3 were
university students. None of the participating patients
took medications likely to impair sleep structure. Four
patients were still tracheotomized and ten had been
transitioned to noninvasive ventilation. One patient suf-
fered from permanent hypoventilation requiring 24-h-a-
day ventilatory assistance (diaphragm pacing during the
day, mechanical ventilation during the night). All other
patients were ventilated only during sleep, but three of
them had documented diurnal hypercapnia. All patients
had undergone at least one previous in-lab polysomno-
graphy, whether as children or as adults. They were in-
formed that their clinical parameters collected during
routine clinical care could be used for research purposes
and they did not refuse this procedure. Fifteen healthy
subjects matched for age, gender and body mass index
and devoid of any sleep complaints were recruited by
word of mouth during the same period, signed an in-
formed consent and received financial compensation.
They were selected for Epworth sleepiness scale ≤ 10, ab-
sence of any sleep complaints, absence of chronic sleep
deprivation, and absence of chronic use of sedative drugs
or alcohol. They were free of any respiratory disease.
The protocol for patients was approved by the ethics
committee of the National Sleep Medicine Society (Soci-
été Française de Recherche et Médecine du Sommeil).
Data concerning healthy subjects were extracted from
another sleep study, in which they were entered as con-
trols and which had been approved by an ethics commit-
tee (Comité de protection des personnes - Ile de France
VI, Paris, France) [10].
Sleep monitoring
Patients and controls were interviewed about sleep
symptoms and completed the Epworth sleepiness scale
[11]. Sleep monitoring included EEG (Fp1/A2, C3/A2,
C3/01), left and right electro-oculograms, surface elec-
tromyogram of mentalis and left and right tibialis anter-
ior muscles, respiratory flow at the mask for patients
and nasal pressure plus tracheal sounds for controls,
ECG, transcutaneous oxygen saturation, thoracic and ab-
dominal efforts through piezoelectric belts and position
monitoring. Patients underwent a single night-time
attended polysomnography with their ventilatory sup-
port. The adequacy of the ventilatory support settings
was documented during the polysomnography by the ab-
sence or quasi-absence of alarms, the absence of epi-
sodes of mask disconnection in patients receiving
noninvasive mechanical ventilation, the absence of sig-
nificant respiratory events (leaks or obstruction), and the
absence of desaturation episodes. The mean SpO2 dur-
ing sleep was 97.5% [96.6; 98.1] and the time with SpO2
below 90% was 0.0% [0.0; 0.2].
The corresponding control subjects were studied on
two consecutive nights. During the first night, respira-
tory variables were recorded together with EEG, which
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demonstrated the absence of sleep-disordered breathing.
Their apnea-hypopnea index was 0.9 [0.0; 1.8], mean
SpO2 during sleep was 96.4% [96.1; 97.6] and the time
with SpO2 below 90% was 0.0% [0.0; 0.0]. During the
second night, designed to compare controls with CCHS
patients, in order to attenuate the influence of the first
night effect, the respiratory sensors were removed to im-
prove comfort. Given the high repeatability of the night-
to-night apnea-hypopnea index in normal subjects [12],
it is reasonable to assume that respiratory events were
not more frequent during the second night than during
the first night.
Sleep stages, and motor and respiratory events were
scored by a single experienced scorer blinded to the sta-
tus (patient or control) of the participants (MAB), ac-
cording to international criteria [13].
Statistical analysis
Data were expressed as median and interquartile range.
Between-group comparisons were performed using the
Mann-Whitney test for continuous measures (anthropo-
metric and sleep data) and Fisher’s exact test for gender,
using online university software resources (biostatgv.sen-
tiweb.fr). A P value less than 0.05 was considered statis-
tically significant.
Results
No significant difference was observed between patients
and controls in terms of gender, age, body mass index,
and score on the Epworth sleepiness scale (Table 1). No
patient or healthy subject complained of insomnia, rest-
less legs syndrome, nightmares, nocturia, morning head-
ache, morning fatigue, daytime fatigue, excessive
daytime sleepiness and need for a daytime nap. Sleep
structure was normal in both groups. The latency to
sleep onset tended to be shorter in patients than in con-
trols, (P = 0.052). The latency to N3 sleep was shorter in
patients than in controls (P = 0.005). No other difference
was observed in terms of sleep duration, continuity,
architecture, and fragmentation, as well as periodic leg
movement index. The three patients exhibiting diurnal
hypercapnia had normal hypnograms. The N1 percent-
ages were 2.8, 5.2 and 4% of total sleep time, respect-
ively. The N2 percentages were 48.8, 49.7 and 45.6%.
The N3 percentages were 34.3, 25.7 and 27.5%. The
REM percentages were 14.2, 19.5 and 22.9%. Mean SaO2
during sleep (97.7, 98.1, and 98.5%, respectively of ), and
minimal SaO2 (91, 95 and 98%, respectively) were in the
adequate range.
Discussion
This study (seemingly the first to describe the sleep
structure in adult patients with CCHS) shows that these
patients, when adequately ventilated, do not exhibit any
sleep abnormalities according to a standard polysomno-
graphy approach. Normal sleep in this genetically homo-
geneous CCHS cohort suggests that the genetic
PHOXB2 defect does not directly impact the brain
structures responsible for sleep and wake. Autonomic
dysregulation during sleep was not assessed in this
study, and we therefore cannot exclude the hypothesis
that autonomic abnormalities such as hypothermia oc-
curred in the CCHS group. However, such abnormalities
apparently did not affect sleep architecture. Failure to
achieve adequate mechanical ventilation during sleep in
chronic respiratory or neurorespiratory diseases requir-
ing ventilatory support during sleep is associated with
impaired sleep efficiency and architecture [14, 15]: by
analogy, CCHS patients reporting sleep complaints
should be primarily investigated for adequate mechanical
Table 1 Demographic, clinical, respiratory and sleep variables in
patients with congenital central hypoventilation syndrome






Gender, F/M 9/5 11/4 0.70
Age, y 23.0 (19.0; 24.8) 23.0 (22.0; 26.0) 0.42
Body mass index, kg/m2 21.7 (20.7; 24.0) 21.7 (20.1; 22.8) 0.95
Epworth sleepiness score,
0-24
7 (2; 8) 6 (4; 7) 0.73
NIV/Tracheotomy 10/4 NA NA
Blood gases
pH 7.42 (7.38; 7.44) NA NA
PaCO2, mmHg 40 (34; 44) NA NA
PaO2, mmHg 101 (86: 112) NA NA
Awake SpO2, % 98 (96; 99) NA NA
Total sleep period, min 514.5 (489.5; 585.8) 552.0 (522.5; 588.5) 0.47
Total sleep time, min 484.0 (432.8; 512.3) 500.0 (446.5; 540.0) 0.42
Sleep efficiency, % 93.7 (82.9; 95.1) 92.9 (88.6; 95.0) 0.86
Latency to, min
Sleep onset 14.0 (7.0; 20.5) 33.0 (18.0; 49.0) 0.052
N3 26.3 (24.0; 30.1) 49.5 (34.3; 66.9) 0.005
REM sleep 64.5 (52.3; 81.5) 64.0 (56.5; 69.0) 0.95
Sleep stages, min
N1 17.5 (10.5; 25.5) 26.0 (15.5; 32.0) 0.21
N2 209.5 (187.3; 247.0) 223.0 (190.0; 245.5) 0.65
N3 117.0 (109.8; 133.8) 120.0 (106.0; 142.0) 0.83
REM sleep 110.0 (90.3; 122.3) 126.0 (109.0; 133.0) 0.11
Arousals (/h) 13.3 (8.5; 17.4) 11.5 (9.2; 15.2) 0.79
Periodic leg movements
(/h)
0.1 (0.0; 3.3) 0.2 (0.0; 0.7) 0.95
NA not available, NIV noninvasive ventilation, Values are median
(interquartile range)
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ventilation. Of note, the majority of patients (ten pa-
tients) were using noninvasive ventilation (the four
remaining patients were still tracheotomized), which is
an effective modality to treat acute respiratory distress in
children with central nervous system disorders [16], and
is recommended after the age of 6 to 8 years and in
adults in patients with stable CCHS [2], and all patients
had optimal respiratory support.
Although situated in the normal range in both groups,
the latency to N3 sleep was shorter in patients than in
controls, and sleep onset latency tended to be shorter in
patients. A reduction of sleep onset and N3 latencies has
been related to improved sleep continuity and quality in
other studies [17]. These signs of excellent sleep in
CCHS suggest that patients relaxed more rapidly
(shorter sleep onset latency) than controls and that their
cortical neurons slowed and synchronized more rapidly
during sleep (shorter N3 sleep latency). A “first night ef-
fect” (which affects sleep onset latency, as well as REM
sleep onset latency and sleep efficiency) could artificially
prolong the sleep onset latency in controls (who are less
used to sleeping with equipment), but not in patients
(who are used to sleeping with mechanical ventilation
since birth and who regularly undergo sleep and oxygen
saturation monitoring). However, this effect was unlikely,
as the comparison was based on the second night in
controls, and in view of the absence of any other evi-
dence of impaired sleep (normal and similar sleep effi-
ciency, duration, structure, as well as normal REM sleep
latency and arousal index). Alternatively, patients with
CCHS could be more isolated from noises and external
disturbances that prolong sleep onset latency. In this re-
spect, children with CCHS have a dysfunction of brain-
stem auditory pathways [18], which may contribute to
“sensory isolation” during sleep and reduce the ability of
the brain to monitor signals despite their possibly vital
importance (e.g., ability to detect ventilator alarms).
However, this speculative interpretation is not supported
by a lower arousal index in patients with CCHS.
The more rapid installation of N3 sleep (and rapid
synchronization and slowing down of cortical neuron ac-
tivity) may indicate a greater need for sleep in patients
with CCHS. The need to use a cortical network to
breathe during wakefulness could possibly be compen-
sated by enhanced restoration of the same cortical net-
work during sleep under mechanical ventilation, as
patients with CCHS exhibit abnormal respiratory-related
cortical activity during awake quiet breathing [6], which
could result in a “compensatory” increase in slow wave
sleep [8, 9]. However, N3 time was normal and similar
in the CCHS and control groups. It would be interesting
to determine whether more subtle signs of cortical res-
toration, such as diffuse or localized changes in the EEG
power spectrum (e.g., increases in delta power), are
observed in these patients. However, the routine EEG
montage was too limited to allow this spatial analysis.
The small size of our sample also prevented us from
drawing any other conclusions. This limitation is inher-
ent to any exceptional disease, but is partially compen-
sated in this case by the genetic and age homogeneity of
the CCHS group.
Conclusion
From a pragmatic point of view, this study shows that
sleep is basically normal in adult patients with CCHS
when they are adequately ventilated. This is reassuring
information for patients and their families. It also means
that any sleep complaint should prompt clinicians to
look for abnormalities unrelated to the genetic disorder
itself, primarily inadequate control of alveolar ventila-
tion, regardless of its mechanisms.
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